The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Progressive Reduction in Cortical Thickness as Psychosis Develops: A Multisite Longitudinal Neuroimaging Study of Youth at Elevated Clinical Risk
Open accessAbstract
Background Individuals at clinical high risk (CHR) who progress to fully psychotic symptoms have been observed to show a steeper rate of cortical gray matter reduction compared with individuals without symptomatic progression and with healthy control subjects. Whether such changes reflect processes associated with the pathophysiology of schizophrenia or exposure to antipsychotic drugs is unknown. Methods In this multisite study, 274 CHR cases, including 35 individuals who converted to psychosis, and 135 healthy comparison subjects were scanned with magnetic resonance imaging at baseline, 12-month follow-up, or the point of conversion for the subjects who developed fully psychotic symptoms. Results In a traveling subjects substudy, excellent reliability was observed for measures of cortical thickness and subcortical volumes. Controlling for multiple comparisons throughout the brain, CHR subjects who converted to psychosis showed a steeper rate of gray matter loss in the right superior frontal, middle frontal, and medial orbitofrontal cortical regions as well as a greater rate of expansion of the third ventricle compared with CHR subjects who did not convert to psychosis and healthy control subjects. Differential tissue loss was present in subjects who had not received antipsychotic medications during the interscan interval and was predicted by baseline levels of an aggregate measure of proinflammatory cytokines in plasma. Conclusions These findings demonstrate that the brain changes are not explained by exposure to antipsychotic drugs but likely play a role in psychosis pathophysiology. Given that the cortical changes were more pronounced in subjects with briefer durations of prodromal symptoms, contributing factors may predominantly play a role in acute-onset forms of psychosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Schizophrenia is associated with accelerated gray matter loss in PFC (Cannon, Chung, He, Sun, Jacobson, van Erp, & Consortium, 2014), including loss of dendrites and spines in the dlPFC (Glantz & Lewis, 2000).”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Cannon et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, there is loss of dlPFC gray matter in schizophrenia4,5 and Alzheimer’s disease6, while changes in more ventral and medial PFC regions are evident in mood disorders7 and in post-traumatic-stress disorder (PTSD)8.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the onset of schizophrenia is accompanied by waves of PFC gray matter loss, as well as increased signs of inflammation5.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, the onset of schizophrenia is accompanied by waves of PFC gray matter loss, as well as increased signs of inflammation5.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As guanfacine is approved by the US Food and Drug Administration for use in adolescents103, it may offer a practical approach for reducing the inflammatory response and gray matter loss found in prodromal schizophrenia5.”
From Stress weakens prefrontal networks: molecular insults to higher cognition (2015) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rao, J. S., Kim, H.-W., Harry, G. J., Rapoport, S. I., & Reese, E. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.017 · Cited by 106
RetractedCortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00569-x · Cited by 8,610
Cortical Surface-Based Analysis
Fischl, B., Sereno, M. I., & Dale, A. M. (1999) · NeuroImage · doi:10.1006/nimg.1998.0396 · Cited by 6,147
Measuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B. R., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,995
Automatically Parcellating the Human Cerebral Cortex
Fischl, B. R. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg087 · Cited by 4,208
Within-subject template estimation for unbiased longitudinal image analysis
Reuter, M., Schmansky, N. J., Rosas, H. D., & Fischl, B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.02.084 · Cited by 2,356
Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics
Woods, S. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0607 · Cited by 2,056
Self-citationHighly accurate inverse consistent registration: A robust approach
Reuter, M., Rosas, H. D., & Fischl, B. R. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.07.020 · Cited by 1,443
Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence?
Feinberg, I. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90038-3 · Cited by 1,395
Cited by
Sorted by citations
Items 301–400 of 600
Sandini, C., Scariati, E., Padula, M. C., Schneider, M., Schaer, M., Ville, D. V. D., & Eliez, S. (2017) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.04.008 · Cited by 19
Cortical Morphometry in the Psychosis Risk Period: A Comprehensive Perspective of Surface Features
Damme, K. S. F., Gupta, T., Nusslock, R., Bernard, J. A., Orr, J. M., & Mittal, V. A. (2018) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2018.01.003 · Cited by 19
Aberizk, K., Collins, M. A., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., Tsuang, M. T., et al. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.04.011 · Cited by 18
Self-citationCurtis, M. T., Coffman, B. A., & Salisbury, D. F. (2020) · Human Brain Mapping · doi:10.1002/hbm.25256 · Cited by 16
Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk
Zhang, D., Xu, L., Xie, Y., Tang, X., Hu, Y., Liu, X., Wu, G., Qian, Z., Tang, Y., Liu, Z., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01463-z · Cited by 17
Cortical Gyrification, Psychotic-Like Experiences, and Cognitive Performance in Nonclinical Subjects
Evermann, U., Gaser, C., Besteher, B., Langbein, K., & Nenadić, I. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa068 · Cited by 17
Foss‐Feig, J. H., Guillory, S. B., Roach, B. J., Velthorst, E., Hamilton, H., Bachman, P., Belger, A., Carrión, R. E., Duncan, E., Johannesen, J., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.591127 · Cited by 17
Self-citationN-Methyl- -Aspartate receptor and inflammation in dorsolateral prefrontal cortex in schizophrenia
Rahman, T., Purves-Tyson, T. D., Geddes, A. E., Huang, X., Newell, K. A., & Weickert, C. S. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.11.045 · Cited by 18
A magnetic resonance imaging family study of cortical thickness in schizophrenia
Goghari, V. M., Truong, W., & Spilka, M. J. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32354 · Cited by 17
Imaging and Genetic Biomarkers Predicting Transition to Psychosis
Hunter, S. A., & Lawrie, S. M. (2018) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_46 · Cited by 17
Reduced cortical thickness in subjects at clinical high risk for psychosis and clinical attributes
Kwak, Y. B., Kim, M., Cho, K. I. K., Lee, J., Lee, T. Y., & Kwon, J. S. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418807299 · Cited by 16
Why you hide what you know: Neuroscience behind knowledge hiding
Issac, A. C., Issac, T. G., Baral, R., Bednall, T. C., & Thomas, T. S. (2021) · Knowledge and Process Management · doi:10.1002/kpm.1677 · Cited by 16
Lizano, P. L., Yao, J. K., Tandon, N., Mothi, S. S., Montrose, D. M., & Keshavan, M. S. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.11.015 · Cited by 15
Plitman, E., Bussy, A., Valiquette, V., Salaciak, A., Patel, R., Cupo, L., Béland, M., Tullo, S., Tardif, C. L., Rajah, M. N., et al. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118172 · Cited by 16
Microglial Activation and the Onset of Psychosis
Cannon, T. D. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15111377 · Cited by 16
Self-citationThe biology of mental disorders: progress at last
Hyman, S. E. (2023) · Daedalus · doi:10.1162/daed_a_02038 · Cited by 15
Computerized Assessment of Psychosis Risk
Mittal, V. A., Ellman, L. M., Strauss, G. P., Walker, E. F., Corlett, P. R., Schiffman, J. E., Woods, S. W., Powers, A. R., Silverstein, S. M., Waltz, J. A., et al. (2021) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20210011 · Cited by 18
Self-citationSaxena, A., & Dodell‐Feder, D. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.831089 · Cited by 15
Hernandez, L. M., Kim, M., Zhang, P., Bethlehem, R. A. I., Hoftman, G. D., Loughnan, R. J., Smith, D. M. Y., Bookheimer, S. Y., Fan, C. C., Bearden, C. E., et al. (2023) · Genome biology · doi:10.1186/s13059-023-02878-0 · Cited by 14
Self-citationRecent Updates on Predicting Conversion in Youth at Clinical High Risk for Psychosis
Caballero, N., Machiraju, S. N., Diomino, A., Kennedy, L., Kadivar, A., & Cadenhead, K. S. (2023) · Current Psychiatry Reports · doi:10.1007/s11920-023-01456-2 · Cited by 17
Self-citationWalker, E. F., Aberizk, K., Yuan, E., Bilgrami, Z. R., Ku, B. S., & Guest, R. M. (2024) · Development and Psychopathology · doi:10.1017/s0954579424000397 · Cited by 18
Self-citationGonzález‐Peñas, J., Alloza, C., Brouwer, R. M., Díaz-Caneja, C. M., Costas, J., Lois, N. G., Gallego, A. G., de Hoyos, L., Gurriarán, X., Andreu-Bernabeu, Á., et al. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.03.011 · Cited by 14
The many roads to psychosis: recent advances in understanding risk and mechanisms
Bearden, C. E., & Forsyth, J. K. (2018) · F1000Research · doi:10.12688/f1000research.16574.1 · Cited by 16
Self-citationThe prodromal phase: Time to broaden the scope beyond transition to psychosis?
Ferrarelli, F., & Mathalon, D. H. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.12.035 · Cited by 15
Self-citationValidation of the Bullying Scale for Adults - Results of the PRONIA-study
Haidl, T. K., Schneider, N., Dickmann, K., Ruhrmann, S., Kaiser, N., Rosen, M., Seves, M., Lichtenstein, T., Upthegrove, R., Salokangas, R. K. R., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.04.004 · Cited by 20
Vargas, T., Damme, K. S. F., Ered, A., Capizzi, R., Frosch, I. R., Ellman, L. M., & Mittal, V. A. (2020) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2020.06.002 · Cited by 15
Rapado‐Castro, M., Whittle, S., Pantelis, C., Thompson, A. D., Nelson, B., Ganella, E. P., Lin, A. P., Reniers, R. L. E. P., McGorry, P. D., Yung, A. R., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.017 · Cited by 15
Keefe, R. S. E., Woods, S. W., Cannon, T. D., Ruhrmann, S., Mathalon, D. H., McGuire, P. K., Rosenbrock, H., Daniels, K., Cotton, D., Roy, D., et al. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.13083 · Cited by 14
Self-citationReward Processing in Mood Disorders and Schizophrenia: A Neurodevelopmental Framework
Nusslock, R., Mittal, V. A., & Alloy, L. B. (2025) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-080822-041621 · Cited by 16
Ku, B. S., Collins, M. A., Anglin, D. M., Diomino, A., Addington, J., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., Druss, B. G., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01649-6 · Cited by 15
Self-citationPrefrontal cortical circuits in social behaviors: an overview
Cao, W., Li, H., & Luo, J. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300743 · Cited by 14
Bourgin, J., Duchesnay, É., Magaud, E., Raphaël Gaillard, B., Kazès, M., & Krebs, M. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01461-y · Cited by 14
Joe, P., Clemente, J. C., Piras, E., Wallach, D. S., Robinson‐Papp, J., Boka, E., Remsen, B., Bonner, M., Kimhy, D., Goetz, D. M., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.09.019 · Cited by 14
Grubisha, M. J., Sun, T., Eisenman, L. R., Erickson, S. L., Chou, S., Helmer, C., Trudgen, M. T., Ding, Y., Homanics, G. E., Penzes, P., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022546118 · Cited by 14
Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers
Wang, S., Yuan, X., Pang, L., Song, P., Jia, R., & Song, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1158254 · Cited by 14
Using Cognitive Neuroscience to Improve Mental Health Treatment: A Comprehensive Review
Wojtalik, J. A., Eack, S. M., Smith, M. J., & Keshavan, M. S. (2018) · Journal of the Society for Social Work and Research · doi:10.1086/697566 · Cited by 17
Makowski, C., Lewis, J. D., Khundrakpam, B. S., Tardif, C. L., Palaniyappan, L. K., Joober, R., MALLA, A. K., Shah, J. L., Bodnar, M. D., Chakravarty, M. M., et al. (2020) · Hippocampus · doi:10.1002/hipo.23215 · Cited by 16
Differential Macrophage Responses in Affective Versus Non-Affective First-Episode Psychosis Patients
Hughes, H. K., Mills-Ko, E., Yang, H. T., Lesh, T. A., Carter, C. S., & Ashwood, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.583351 · Cited by 13
West, M. L., Guest, R. M., & Carmel, A. (2021) · Personality and Mental Health · doi:10.1002/pmh.1509 · Cited by 14
Hidalgo, S., Campusano, J. M., & Hodge, J. J. L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01418-3 · Cited by 14
Response to targeted cognitive training may be neuroprotective in patients with early schizophrenia
Ramsay, I. S., Fryer, S. L., Roach, B. J., Boos, A. K., Fisher, M., Loewy, R. L., Ford, J. M., Vinogradov, S., & Mathalon, D. H. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111285 · Cited by 13
Self-citationNeuropsychiatric disorders: An immunological perspective
Aw, E., Zhang, Y., Yalçın, E., Herrmann, U., & Carroll, M. C. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.002 · Cited by 13
Forsyth, J. K., & Bearden, C. E. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230736 · Cited by 12
Self-citationFukatsu-Chikumoto, A., Hirano, T., Takahashi, S., Ishida, T., Yasuda, K., Donishi, T., Suga, K., Doi, K., Oishi, K., Ohata, S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-53933-0 · Cited by 12
Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia
Arnsten, A. F. T., & Datta, D. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240731 · Cited by 12
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
Harms, M. P., Cho, K. I. K., Anticevic, A., Bolo, N. R., Sylvain Bouix, A., Campbell, D., Cannon, T. D., Cecchi, G., Goncalves, M., Haidar, A., et al. (2025) · Schizophrenia · doi:10.1038/s41537-025-00581-6 · Cited by 13
Self-citationDevelopmental Trajectories of Cortical Thickness in Relation to Schizotypy During Adolescence
Derome, M., Tonini, E., Zöller, D., Schaer, M., D, S. E. M., & Debbané, M. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa020 · Cited by 12
Worthington, M., Collins, M. A., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Keshavan, M. S., Mathalon, D. H., Perkins, D. O., Stone, W. S., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291723002301 · Cited by 12
Self-citationAssessment of Risk for Psychosis
Shapiro, D. I., Li, H., Kline, E. R., & Niznikiewicz, M. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-17336-4_2 · Cited by 13
Towards a framework to develop neuroimaging biomarkers of relapse in schizophrenia
Rubio, J. M., Malhotra, A. K., & Kane, J. M. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113099 · Cited by 13
Dodell‐Feder, D., Tully, L. M., Dudek, E. M., & Hooker, C. I. (2021) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsab028 · Cited by 13
Collins, M. A., Chung, Y., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Mathalon, D. H., McGlashan, T. H., Perkins, D. O., Seidman, L. J., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102757 · Cited by 12
Self-citationRelation between cannabis use and subcortical volumes in people at clinical high risk of psychosis
Buchy, L., Mathalon, D. H., Cannon, T. D., Cadenhead, K. S., Cornblatt, B. A., McGlashan, T. H., Perkins, D. O., Seidman, L. J., Tsuang, M. T., Walker, E. F., et al. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.06.001 · Cited by 13
Self-citationLane, N. M., Hunter, S. A., & Lawrie, S. M. (2020) · NeuroImage: Clinical · doi:10.1016/j.nicl.2020.102228 · Cited by 11
Fortea, A., van Eijndhoven, P., Calvet-Mirabent, À., Ilzarbe, D., Batalla, A., de la Serna, E., Puig, O., Castro‐Fornieles, J., Dolz, M., Tor, J., et al. (2023) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-023-02278-6 · Cited by 11
Weickert, T. W., Ji, E., Galletly, C. A., Boerrigter, D., Morishima, Y., Bruggemann, J. M., Balzan, R. P., O׳Donnell, M., Liu, D., Lenroot, R., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad171 · Cited by 12
Multimodal fusion of brain signals for robust prediction of psychosis transition
Reinen, J., Polosecki, P. I., Castro, E., Corcoran, C. M., Cecchi, G., & Colibazzi, T. (2024) · Schizophrenia · doi:10.1038/s41537-024-00464-2 · Cited by 13
Analysis of the complement component C4 gene with schizophrenia subphenotypes
Chen, C. C., Howie, J., Ebrahimi, M., Teymouri, K., Woo, J., Tiwari, A. K., Zai, C. C. H., & Kennedy, J. L. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.039 · Cited by 11
Inflammation in Schizophrenia: The Role of Disordered Oscillatory Mechanisms
Speers, L. J., & Bilkey, D. K. (2025) · Cells · doi:10.3390/cells14090650 · Cited by 12
Karanikas, E., Griveas, I., Ntouros, E., Floros, G. D., & Garyfallos, G. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.07.059 · Cited by 11
Psychotic symptoms are associated with lower cortical folding in youth at risk for mental illness
Drobinin, V., Gestel, H. V., Zwicker, A., MacKenzie, L. E., Cumby, J., Patterson, V. C., Vallis, E. H., Campbell, N., Hájek, T., Helmick, C. A., et al. (2020) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.180144 · Cited by 10
Psychosis symptoms associated with Niemann-Pick disease type C
Ong, L. T. (2021) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000286 · Cited by 11
Cognitive Dysfunction as a Risk Factor for Psychosis
Karcher, N. R., Merchant, J. T., Pine, J. G., & Kilçiksiz, C. M. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_387 · Cited by 11
Muhtaseb, A. W., & Duan, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.04.003 · Cited by 11
Zhang, T., Xu, L., Tang, X., Wei, Y., Hu, Y., Cui, H., Tang, Y., Li, C., & Wang, J. (2023) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.152 · Cited by 12
Weng, T., Zheng, Y., Xie, Y., Qin, W., & Guo, L. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148876 · Cited by 14
Complement Cascades and Brain Disorders
Jovčevska, I., Paska, A. V., & Kouter, K. (2025) · Biomolecules · doi:10.3390/biom15081179 · Cited by 11
Jacob, M., Roach, B. J., Hamilton, H., Carrión, R. E., Belger, A., Duncan, E., Johannesen, J., Keshavan, M. S., Loo, S. K., Niznikiewicz, M. A., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.01.028 · Cited by 13
Self-citationForecasting prognostic trajectories with mismatch negativity in early psychosis
Kim, M., Kim, T., Hwang, W. J., Lho, S. K., Moon, S., Lee, T. Y., & Kwon, J. S. (2021) · Psychological Medicine · doi:10.1017/s0033291721003068 · Cited by 10
Tognin, S., Richter, A., Kempton, M. J., Modinos, G., Antoniades, M., Azis, M., Allen, P., Bossong, M. G., Pérez, J., Pantelis, C., et al. (2022) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgac040 · Cited by 10
Aberizk, K., Sefik, E., Addington, J., Anticevic, A., Bearden, C. E., Cadenhead, K. S., Cannon, T. D., Cornblatt, B. A., Keshavan, M. S., Mathalon, D. H., et al. (2023) · Clinical Psychological Science · doi:10.1177/21677026221138819 · Cited by 10
Self-citationN100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic Youth
Gonzalez–Heydrich, J., Enlow, M. B., D’Angelo, E. J., Seidman, L. J., Gumlak, S., Kim, A., Woodberry, K. A., Rober, A., Tembulkar, S. K., O’Donnell, K., et al. (2016) · Neural Plasticity · doi:10.1155/2016/4209831 · Cited by 12
Self-citationSakuma, A., Obara, C., Katsura, M., Ito, F., Ohmuro, N., Iizuka, K., Kikuchi, T., Miyakoshi, T., Matsuoka, H., & Matsumoto, K. (2018) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2018.09.009 · Cited by 9
Bonoldi, I., Allen, P., Madeira, L., Tognin, S., Bossong, M. G., Azis, M., Samson, C., Quinn, B., Calem, M., Valmaggia, L., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00254 · Cited by 11
Mackey, M., Holleran, L., Donohoe, G. J., & McKernan, D. P. (2022) · Psychiatry Investigation · doi:10.30773/pi.2022.0173 · Cited by 10
Associations and Heritability of Auditory Encoding, Gray Matter, and Attention in Schizophrenia
Chen, Y., Howell, B. C., Edgar, J. C., Huang, M., Kochunov, P. V., Hunter, M. A., Wootton, C., Lu, B. Y., Bustillo, J., Sadek, J. R., et al. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby111 · Cited by 10
Trajectories of brain volume change over 13 years in chronic schizophrenia
Barth, C., Jørgensen, K. N., Wortinger, L. A., Nerland, S., Jönsson, E. G., & Agartz, I. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.05.014 · Cited by 10
Metzak, P. D., Devoe, D. J. A., Iwaschuk, A., Braun, A., & Addington, J. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.07.041 · Cited by 10
Self-citationHeinrichs, R. W., Pinnock, F., Parlar, M. E., Hawco, C. S., Hanford, L. C., & Hall, G. B. (2017) · Schizophrenia Research and Treatment · doi:10.1155/2017/9760905 · Cited by 9
Schizophrenia Polygenic Risk During Typical Development Reflects Multiscale Cortical Organization
Kirschner, M., Paquola, C., Khundrakpam, B. S., Vainik, U., Bhutani, N., Hodzic-Santor, B. H., Georgiadis, F., Al‐Sharif, N., Mišić, B., Bernhardt, B. C., et al. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.08.003 · Cited by 15
A Review of Potential Neuroimaging Biomarkers of Schizophrenia-Risk
Mamah, D. T. (2023) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20230005 · Cited by 9
Cho, K. I. K., Zhang, F., Penzel, N., Seitz‐Holland, J., Tang, Y., Zhang, T., Xu, L., Li, H., Keshavan, M. S., Whitfield, S., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02597-3 · Cited by 9
Is neuroimaging clinically useful in subjects at high risk for psychosis?
Borgwardt, S., & Schmidt, A. (2016) · World Psychiatry · doi:10.1002/wps.20333 · Cited by 8
Psychiatric syndromes other than dementia
Bechter, K., & Deisenhammer, F. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804279-3.00017-4 · Cited by 9
The Current State of the Clinical High Risk for Psychosis Research Paradigm
Cannon, T. D. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.06.008 · Cited by 9
Self-citationKoike, S., Uematsu, A., Sasabayashi, D., Maikusa, N., Takahashi, T., Ohi, K., Nakajima, S., Noda, Y., & Hirano, Y. (2021) · Magnetic Resonance in Medical Sciences · doi:10.2463/mrms.rev.2021-0050 · Cited by 10
The Future of Psychoneuroimmunology: Promises and Challenges
Halaris, A. E., Bechter, K., Haroon, E., Leonard, B. E., Miller, A. H., Pariante, C. M., & Zunszain, P. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-70554-5_15 · Cited by 9
Deciphering the Genetic Complexity of Schizophrenia
Cannon, T. D. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2111 · Cited by 9
Self-citationRicci, V., Sarni, A., Martinotti, G., & Maina, G. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104725 · Cited by 10
Is it possible to prevent excessive synaptic pruning in schizophrenia? Possibilities and limitations
Pawlak, A., Stefanowicz, J., Kotkowska, Z., Gabryelska, A., Sochal, M., Napieraj, F., Kotlicka‐Antczak, M., & Strzelecki, D. (2025) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2025.1656232 · Cited by 9
Hua, J. P. Y., Loewy, R. L., Stuart, B. K., Fryer, S. L., Niendam, T. A., Carter, C. S., Vinogradov, S., & Mathalon, D. H. (2023) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2023.111653 · Cited by 8
Self-citationBüetiger, J. R., Hubl, D., Kupferschmid, S., Schultze‐Lutter, F., SCHIMMELMANN, B. G., Federspiel, A., Hauf, M., Walther, S., Kaess, M., Michel, C., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.535652 · Cited by 8
Animal Models of Relevance to the Schizophrenia Prodrome
Petty, A. E., Howes, O. D., & Eyles, D. W. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.001 · Cited by 8
RETRACTED: Dynamic Prediction of Outcomes for Youth at Clinical High Risk for Psychosis
Worthington, M., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Keshavan, M. S., Lympus, C. A., Mathalon, D. H., Perkins, D. O., Stone, W. S., et al. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.2378 · Cited by 8
Self-citationRetractedKonishi, J. S., del Re, E. C., Sylvain Bouix, A., Blokland, G. A. M., Mesholam‐Gately, R. I., Woodberry, K. A., Niznikiewicz, M. A., Goldstein, J. M., Hirayasu, Y., Petryshen, T. L., et al. (2017) · Brain Imaging and Behavior · doi:10.1007/s11682-017-9758-z · Cited by 8
Self-citationJalbrzikowski, M., Liu, F., Foran, W., Roeder, K., Devlin, B., & Luna, B. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz053 · Cited by 9
Collaborative Approaches to the Clinical High-Risk State: From Data to Mechanism to Intervention
Gordon, J. A., & HEINSSEN, R. K. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.027 · Cited by 8
Self-citationCadenhead, K. S., Mirzakhanian, H., Achim, C. L., Reyes-Madrigal, F., & de la Fuente‐Sandoval, C. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.11.012 · Cited by 7
Self-citationHusain, M. O., Jones, B., Arshad, U., Ameis, S. H., Mirfallah, G., Schifani, C., Rodak, T., Aiken, M., Shafique, M. S., Ahmed, F., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05788-y · Cited by 9
McCrea, L. T., Batorsky, R., Bowen, J. J., Yeh, H., Thanos, J. M., Fu, T., Perlis, R. H., & Sheridan, S. D. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02123-1 · Cited by 7
Metadata
- Authors
- Cannon, T. D., Chung, Y., He, G., Sun, D., Jacobson, A., van Erp, T. G. M., McEwen, S., Addington, J., Bearden, C. E., Cadenhead, K., Cornblatt, B., Mathalon, D. H., McGlashan, T., Perkins, D., Jeffries, C., Seidman, L. J., Tsuang, M., Walker, E., Woods, S. W., & Heinssen, R.
- Affiliations
- Yale University (US)
- University of California, Los Angeles (US)
- University of California, Irvine (US)
- University of Calgary (CA)
- University of California San Diego (US)
- Zucker Hillside Hospital (US)
- University of California, San Francisco (US)
- University of North Carolina at Chapel Hill (US)
- Beth Israel Deaconess Medical Center (US)
- Emory University (US)
- National Institute of Mental Health (US)
- Corresponding author
- Cannon, Tyrone D.
- ORCID
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 77
- Issue
- 2
- Pages
- 147-157
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC4264996
- OpenAlex
- W2166663076
- Cited by
- 599
- References
- 63
- Citations by year
- 2026: 28 · 2025: 28 · 2024: 38 · 2023: 49 · 2022: 44 · 2021: 73 · 2020: 73 · 2019: 78 · 2018: 38 · 2017: 43 · 2016: 54 · 2015: 44
- FWCI
- 37.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Commonwealth of Massachusetts
- National Institute of Mental Health
- National Institutes of Health (MH081902, MH066160, MH081928, MH081857, MH082004, P50 MH080272, MH081988, P50 MH066286, MH082022, MH081984)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- clinical high risk for psychosis, transition to psychosis, cortical thickness, gray matter loss, schizophrenia pathophysiology, inflammatory cytokines, frontal cortex, prodromal symptoms, youth
- MeSH terms
- Adolescent, Cerebral Cortex, Female, Follow-Up Studies, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Organ Size, Psychotic Disorders, Risk, Antipsychotic Agents, Reproducibility of Results, Cytokines, Disease Progression, Young Adult, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
